Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of FDG Positron Emission Tomography (PET)in Patient With Hodgkin Lymphoma (HL) in the "Real World": a Population Based Study From Northern Italy

NCT01248000 is registered in ClinicalTrials.gov with Gruppo Italiano Studio Linfomi as lead sponsor.

NCT NCT01248000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01248000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of FDG Positron Emission Tomography (PET)in Patient With Hodgkin Lymphoma (HL) in the "Real World": a Population Based Study From Northern Italy
Lead sponsor
Gruppo Italiano Studio Linfomi
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
May 31, 2010
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

histologically confirmed classical hodgkin lymphoma according to the current world health organisation classification